Showing results (311-320 of 318) with videos related to
Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 318 results.
The Journal of Antimicrobial Chemotherapy|November 30, 2017
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trialPierre de Truchis, Lambert Assoumou, Roland Landman, et al.Critical Care (London, England)|January 9, 2023
Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trialTarek Sharshar, Raphaël Porcher, Pierre Asfar, et al.The Lancet. HIV|February 5, 2022
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trialRoland Landman, Pierre de Truchis, Lambert Assoumou, et al.Gut|June 3, 2025
Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome StudyManolo Laiola, Laetitia Koppe, Amine Larabi, et al.Gut Microbes|July 13, 2026
Lactiplantibacillus plantarum WJL ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein dietBerengère Benoit, Pierre Letourneau, Vincent Verdier, et al.Annals of Intensive Care|November 23, 2020
Management of pharmaceutical and recreational drug poisoningBruno Mégarbane, Mathieu Oberlin, Jean-Claude Alvarez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational StudyJean Donadieu, Islam Amine Larabi, Mathilde Tardieu, et al.Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.Pageof 32